| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/09/1999 | US5869444 Osmotic agents for peritoneal dialysis |
| 02/09/1999 | US5869306 Gene transfer preparation |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869266 Human olfactory neuron cultures to diagnose Alzheimer's disease |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869248 Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| 02/09/1999 | US5869230 Gene transfer into the kidney |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869054 Treatment of multiple sclerosis by oral administration of autoantigens |
| 02/09/1999 | US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
| 02/09/1999 | US5869044 Method for the treatment or prophylaxis of ischemia-reperfusion injury |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | CA1340381C Recombinant fusion proteins |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/04/1999 | WO1999005174A1 The ha-1 antigen |
| 02/04/1999 | WO1999005173A1 The ha-1 antigen |
| 02/04/1999 | WO1999004805A1 Anti-inflammatory factor, method of isolation, and use |
| 02/04/1999 | WO1999004804A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | WO1999004649A1 A processed food containing probiotic microorganisms, starch/dietary fibre and, stabilisers/emulsifiers |
| 02/04/1999 | WO1998050079A3 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 02/04/1999 | DE19811402A1 Preparation of medicaments for treatment of tumours |
| 02/04/1999 | CA2298887A1 The ha-1 antigen |
| 02/04/1999 | CA2297183A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 02/03/1999 | EP0894862A2 Novel CysS |
| 02/03/1999 | EP0894857A2 SecA gene from Streptococcus pneumoniae |
| 02/03/1999 | EP0894129A1 Short external guide sequences |
| 02/03/1999 | EP0894127A2 Methods for increasing the maturation of cells |
| 02/03/1999 | EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY |
| 02/03/1999 | EP0894001A1 Inhibitor of immunoglobulin e antibody production |
| 02/03/1999 | CN1206609A External medicine for curing respiratory tract disease |
| 02/03/1999 | CN1206607A Medicine for curing bone fracture |
| 02/03/1999 | CN1206604A Capsule for improving blood circulation and reducing fat |
| 02/03/1999 | CN1206601A Traditional Chinese medicine prescription for tonifying the kidney reinforcing the spleen and nourishing the blood and preparation process |
| 02/03/1999 | CN1206600A Multi-effect nutrient health care medicinal liquor prescription for old and middle-aged people and preparation process thereof |
| 02/03/1999 | CN1206597A Xiaojieling and preparation process thereof |
| 02/03/1999 | CN1206595A Thrombus dissolving Guiluchun |
| 02/03/1999 | CN1206594A Process for preparing antidote of Soman intoxication |
| 02/03/1999 | CN1041934C Process for preparing and/or purifying bar acid or medicinal salt or ester thereof |
| 02/02/1999 | US5866757 Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems |
| 02/02/1999 | US5866551 Therapy for atherosclerosis |
| 02/02/1999 | US5866539 Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 02/02/1999 | US5866535 Forming antibodies |
| 02/02/1999 | US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders |
| 02/02/1999 | US5866415 Materials for healing cartilage and bone defects |
| 02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866323 Cancer diagnosis prognosis and therapy based on mutation of receptors for transforming growth factor β and homologous growth controlling factors |
| 02/02/1999 | US5866167 Culture product |
| 02/02/1999 | US5866160 Human therapy |
| 02/02/1999 | US5866130 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 02/02/1999 | US5866115 Process for preparing dendritic cells, cells thus produced and containers for carrying out this process |
| 02/02/1999 | US5865785 Systems and methods for on line finishing of cellular blood products like platelets harvested for therapeutic purposes |
| 02/02/1999 | US5865784 Method of hemodilution facilitated by monitoring oxygenation status |
| 02/02/1999 | US5865744 Method and system for delivering therapeutic agents |
| 02/02/1999 | CA1340369C Antisense oligonucleotides to c-myb proto-oncogene and uses thereof |
| 02/01/1999 | CA2238672A1 Seca |
| 01/28/1999 | WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | WO1999004026A2 Lentiviral vectors |
| 01/28/1999 | WO1999003976A2 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 01/28/1999 | WO1999003973A1 Cardiac muscle regeneration using mesenchymal stem cells |
| 01/28/1999 | WO1999003890A1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 01/28/1999 | WO1999003557A1 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1999003505A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 01/28/1999 | WO1999003483A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/28/1999 | WO1999003350A1 Therapeutic substance for use in the treatment of aids and immuno-allergical diseases |
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | DE19731154A1 New endothelial cells prepared from non-adherent mononuclear cells |
| 01/28/1999 | CA2521392A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/28/1999 | CA2296366A1 Method of treating leukocytes, leukocyte compositions and methods of use thereof |
| 01/28/1999 | CA2296319A1 Lentiviral vectors |
| 01/28/1999 | CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 01/28/1999 | CA2294934A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892852A2 Cytochrome p450 transducing retroviral vectors |
| 01/27/1999 | EP0892599A1 Method for removal of psoralens from biological fluids |
| 01/27/1999 | CN1206349A Pharmaceutical composition comprising plant worms and muirapuama |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1205879A Piles-eliminating pill and its preparation |
| 01/27/1999 | CN1041800C Preparation of capsule for curing spondylopathy |
| 01/26/1999 | US5864016 Treating the blood product with an aqueous solution containing a detergent and heating in the solid state; deactivation of viral activity relative to infectious agents but maintaining at least 50% of its biological activity |
| 01/26/1999 | US5863938 Wound healing agent comprises pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid and mixtures thereof; antioxidant; mixture of saturated and unsaturated fatty acids |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport |
| 01/26/1999 | US5863797 Gene fusion encoding a hypersecretor protein |
| 01/26/1999 | US5863561 Milk containing non-immunoglobulin polypeptide fragments of the allergens used to immunize the animal; antiallergens; vaccines |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/26/1999 | US5863531 In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| 01/26/1999 | US5863528 Porcine cytokines |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238665A1 Novel reductase |